Eli Lilly and Co — Moat
MOAT ASSESSMENT TICKER: [US.LLY - Eli Lilly and Co] PERIOD: [2010-ANNUAL ~ 2025-ANNUAL] Parameter Value ---------------- WACC 10% [+] ROIC Mean: 35.4% (> 15% = high returns) [~] ROIC Stability: 9.8% (StdDev < 5% = highly stable) [+] Gross Margin Stability: 3.5% (CoV < 10% = stable pricing power) [+] Economic Moat (ROIC-WACC): 25.4% (> 5% = creating economic value) Metric Value -------------------------------- ROIC 5Y Mean 35.4% ROIC Stability (σ) 9.8% Gross Margin CoV 3.5% Revenue Growth R² 0.47 Economic Moat (ROIC-WACC) 25.4%
audit moat
MOAT ASSESSMENT
TICKER: [US.LLY - Eli Lilly and Co]
PERIOD: [2010-ANNUAL ~ 2025-ANNUAL]
Parameter Value----------------WACC 10%
[+] ROIC Mean: 35.4% (> 15% = high returns)[~] ROIC Stability: 9.8% (StdDev < 5% = highly stable)[+] Gross Margin Stability: 3.5% (CoV < 10% = stable pricing power)[+] Economic Moat (ROIC-WACC): 25.4% (> 5% = creating economic value)
Metric Value--------------------------------ROIC 5Y Mean 35.4%ROIC Stability (σ) 9.8%Gross Margin CoV 3.5%Revenue Growth R² 0.47Economic Moat (ROIC-WACC) 25.4%